Profil
Charles Reay Mackay is the founder and director of G2 Therapies Pty Ltd, which was founded in 2002.
He was also the Head of Immunology & Inflammation Programme at The Garvan Institute of Medical Research.
Postes actifs de Charles Reay Mackay
| Sociétés | Poste | Début |
|---|---|---|
G2 Therapies Pty Ltd.
G2 Therapies Pty Ltd. BiotechnologyHealth Technology Develops novel antibody based therapies in inflammation and cancer | Fondateur | 29/10/2010 |
Anciens postes connus de Charles Reay Mackay
| Sociétés | Poste | Fin |
|---|---|---|
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
G2 Therapies Pty Ltd.
G2 Therapies Pty Ltd. BiotechnologyHealth Technology Develops novel antibody based therapies in inflammation and cancer | Health Technology |
The Garvan Institute of Medical Research
The Garvan Institute of Medical Research Miscellaneous Commercial ServicesCommercial Services Provides biomedical research | Commercial Services |
















